Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29919493 | 0.87 | PGR (0.46) | ALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL5894861 | 0.87 | PGR (0.46) | ALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL379394 | 0.85 | ESR1 (0.46) | ALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL31490381 | 0.85 | ESR1 (0.46) | ALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL2640042 | 0.85 | ESR1 (0.46) | ALDH1A1L3MBTL1ESR1ESR2 | |
| SCHEMBL4922107 | 0.83 | PGR (0.45) | ESR1ESR2HTR2A | |
| SCHEMBL29473421 | 0.83 | PGR (0.45) | ESR1ESR2HTR2A | |
| SCHEMBL30673333 | 0.83 | PGR (0.45) | ESR1ESR2HTR2A | |
| SCHEMBL8766211 | 0.83 | HSD11B1 (0.53) | PDE7ASLC6A4SLC6A3 | |
| SCHEMBL14198317 | 0.83 | HTR2A (0.35) | ESR1ESR2HTR2APDE7A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6759103-B2 | NEMATIC, CHOLESTERIC OR CHIRAL SMECTIC LIQUID-CRYSTAL MIXTURES HAVING HIGH ABSOLUTE DIELECTRIC ANISOTROPY VALUES AND WITH A FAVORABLE VISCOSITY/CLEARING POINT RELATIONSHIP; PHOTOSTABILITY; HEAT AND ULTRAVIOLET RADIATION RESISTANCE | CLARIANT FINANCI (BVI) LIMITED (VG) | 2004-07-06 | — | — | US | disclosed |
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | CLARIANT INTERNATIONAL LTD. | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | SCO2, CNOT1, HCFC1 | ALDH1A1 1699/4885L3MBTL1 313/4885ESR1 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.